Swisse controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile4 entries
2026
Swisse recalls two Beauty Skin Regeneration+ batches in Australia
Recall announced
Swisse stated that its Australian company identified during routine self-inspection that batches 144520 and 143217 of Beauty Skin Regeneration+ had lead levels slightly above the standard limit, and it proactively recalled the batches. The brand said the recall was confined to controlled parts of the Australian market and that the products had not reached consumers.
Swisse said its Australian company found that batches 144520 and 143217 of Beauty Skin Regeneration+ had lead levels slightly above the standard limit during routine self-inspection and had proactively recalled the batches. The brand said the recall was confined to controlled parts of the Australian market and the products had not reached consumers.
Company response
Clarification — Swisse
经核实，本次涉及批次仅存在于澳洲，从未进入中国市场。目前在中国正规渠道销售的所有产品，均严格符合澳大利亚TGA及中国国家标准要求，品质安全不受影响，请广大消费者放心选购。
Source excerpt
Swisse澳洲公司在例行自检过程中发现该产品批次144520、143217存在铅含量轻微超出标准的情况，基于Swisse高标准质量体系和对消费者安全的高度重视，公司已主动召回相关批次，并且产品在澳洲市场可控环节召回，相关产品并未流入消费者端。
经核实，本次涉及批次仅存在于澳洲，从未进入中国市场。目前在中国正规渠道销售的所有产品，均严格符合澳大利亚TGA及中国国家标准要求，品质安全不受影响，请广大消费者放心选购。
Swisse斯维诗澳洲公司发现该产品批次144520、143217存在铅含量轻微超出标准的情况，基于Swisse高标准质量体系和对消费者安全的高度重视，公司已主动召回相关批次，并且产品在澳洲市场可控环节召回。经核实，本次涉及批次仅存在于澳洲，从未进入中国市场。
2025
Environmental criticism of krill-oil products
The Bob Brown Foundation launched a campaign against Swisse's sale of krill oil, raising concerns about environmental damage associated with krill harvesting and the wider marine ecosystem.
2013
Appetite-suppression product evidence dispute
A broadcast report questioned the handling of clinical tests for a Swisse appetite suppressant. The TGA later nullified the product's registration because it found insufficient evidence for the indications and considered the presentation unacceptable. A related defamation case was settled out of court without a payment by either party.
2012
Regulatory action over advertising claims
The TGA Complaints Resolution Panel ordered Swisse to stop using the claims “clinically proven” and “independently tested,” along with a tagline promising improved wellbeing.